Predictive molecular pathology in the time of COVID-19

In the time of COVID-19, predictive molecular pathology laboratories must still timely select oncological patients for targeted treatments. However, the need to respect social distancing measures may delay results generated by laboratory-developed tests based on sequential steps a long hands-on time. Laboratory workflows should now be simplified.The organisation of the University of Naples Federico II predictive pathology laboratory was assessed...